Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 13, 2021Molecular TherapyOpen Access

Targeting of pancreatic cancer cells and stromal cells using engineered oncolytic Salmonella typhimurium

View Full Paper
Ask AI
Bookmark
Share

Authors

WTWenzhi TanHunan UniversityMDMai T. DuongNong Lam University Ho Chi Minh CityCZChaohui ZuoCentral South University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Tan et al. (2021) studied this question.

synapsesocial.com/papers/6aa7079548488c877481297ahttps://doi.org/10.1016/j.ymthe.2021.08.023
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Cancer Statistics, 20212021 · 17,462 citations
  2. 2Enzymatic Depletion of Tumor Hyaluronan Induces Antitumor Responses in Preclinical Animal Models2010 · 302 citations
  3. 3Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma2010 · 1,281 citations
  4. 4Two-step enhanced cancer immunotherapy with engineered Salmonella typhimurium secreting heterologous flagellin2017 · 587 citations
  5. 5Salmonella typhimurium Suppresses Tumor Growth via the Pro-Inflammatory Cytokine Interleukin-1β2015 · 200 citations